Related Experiment Video
Updated: Jun 28, 2025

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast
Sahar Sarmasti Emami1, Anni Ge1, Derek Zhang1
1Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON K7L 3N6, Canada.
Abstract:
The Hippo pathway plays crucial roles in governing various biological processes during tumorigenesis and metastasis. Within this pathway, upstream signaling stimuli activate a core kinase cascade, involving MST1/2 and LATS1/2, that subsequently phosphorylates and inhibits the transcriptional co-activators YAP and its paralog TAZ. This inhibition modulates the transcriptional regulation of downstream target genes, impacting cell proliferation, migration, and death. Despite the acknowledged significance of protein kinases in the Hippo pathway, the regulatory influence of protein phosphatases remains largely unexplored. In this study, we conducted the first gain-of-functional screen for protein tyrosine phosphatases (PTPs) regulating the Hippo pathway. Utilizing a LATS kinase biosensor (LATS-BS), a YAP/TAZ activity reporter (STBS-Luc), and a comprehensive PTP library, we identified numerous novel PTPs that play regulatory roles in the Hippo pathway. Subsequent experiments validated PTPN12, a master regulator of oncogenic receptor tyrosine kinases (RTKs), as a previously unrecognized negative regulator of the Hippo pathway effectors, oncogenic YAP/TAZ, influencing breast cancer cell proliferation and migration. In summary, our findings offer valuable insights into the roles of PTPs in the Hippo signaling pathway, significantly contributing to our understanding of breast cancer biology and potential therapeutic strategies.
Insights
Protein tyrosine phosphatases (PTPs) regulate the Hippo pathway, impacting cancer. Researchers identified novel PTPs, including PTPN12, as key regulators of YAP/TAZ activity, offering new therapeutic targets for breast cancer.
Area of Science:
- Cell Biology
- Biochemistry
- Oncology
Background:
- The Hippo pathway is vital for controlling cell proliferation, migration, and apoptosis during tumorigenesis and metastasis.
- While protein kinases in the Hippo pathway are well-studied, the role of protein phosphatases remains largely unknown.
- YAP and TAZ are key transcriptional co-activators inhibited by the Hippo pathway's kinase cascade.
Purpose of the Study:
- To identify protein tyrosine phosphatases (PTPs) that regulate the Hippo signaling pathway.
- To investigate the role of PTPN12 as a potential regulator of Hippo pathway effectors in breast cancer.
Main Methods:
- Conducted a gain-of-function screen using a comprehensive PTP library.
- Employed a LATS kinase biosensor (LATS-BS) and a YAP/TAZ activity reporter (STBS-Luc).
- Validated findings through subsequent experimental investigations.
Main Results:
- Identified numerous novel PTPs involved in regulating the Hippo pathway.
- Validated PTPN12 as a previously unrecognized negative regulator of YAP/TAZ.
- Demonstrated PTPN12's influence on breast cancer cell proliferation and migration.
Conclusions:
- Protein tyrosine phosphatases play significant regulatory roles in the Hippo signaling pathway.
- PTPN12 emerges as a key regulator of oncogenic YAP/TAZ, impacting breast cancer progression.
- These findings provide insights into breast cancer biology and potential therapeutic avenues targeting PTPs.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
The JAK-STAT Signaling Pathway
Hedgehog Signaling Pathway
Abnormal Proliferation